Web2 dic 2024 · Immune checkpoint inhibitors (ICIs) have transformed the treatment paradigm for solid tumors. However, even in cancers generally considered ICI-sensitive, responses can vary significantly. Thus, there is an ever-increasing interest in identifying novel means of improving therapeutic responses, both … WebDr. Hidayatullah Munshi, MD is an oncologist in Chicago, Illinois. He is affiliated with Northwestern Memorial Hospital and Jesse Brown Veterans Affairs Medical Center.
Dr. Hidayatullah G. Munshi, MD Chicago, IL Oncologist US …
Web10 apr 2024 · Sameem Abedin, Craig S. Boddy, Hidayatullah G. Munshi Oct4/Sox2 binding sites contribute to maintaining hypomethylation of the maternal igf2/h19 imprinting control region. David L. Zimmerman ... WebHidayatullah Munshi, MD Professor, Medicine, Hematology Oncology Division; Feinberg School of Medicine Research Program Tumor Environment and Metastasis (TEAM) Email [email protected] Cancer-Focused Research mya my love is like whoa instrumental
Nab-Paclitaxel and Gemcitabine as First-line Treatment of ... - PubMed
WebHidayatullah G. Munshi, MD, ... Dr. Hidayatullah Munshi initiated studies to characterize the genome expression profile changes upon treatment of metarrestin in pancreatic cells (PANC1 and PC3M cells) in culture. Metarrestin is a novel, anti-metastasis drug for treatment of advanced stage pancreatic Web1 mar 2024 · Gα13 transduces signals from G-protein-coupled receptors. While Gα13 functions as a tumor suppressor in lymphomas, it is not known whether Gα13 is pro-tumorigenic or tumor suppressive in genetically engineered mouse (GEM) models of epithelial cancers. Here, we show that loss of Gα13 in the Kras/Tp53 … Web22 giu 2024 · While half of the metastatic clear cell renal cell carcinomas (ccRCCs) involve the lungs, metastatic lesions have been described in various other organs, including glandular tissues such as the pancreas. Recent evidence suggests that ccRCC lesions affecting the pancreas are poorly responsive to immu … mya mya production